In line with these findings, levels of IL-13 in the CSF of MS patients are positively correlated with axonal and neuronal integrity as well as with better performance in Multiple Sclerosis Functional Composite (MSFC) scoring [101]. The gene discussed is IL13; the disease is myeloid sarcoma.